We refer to the announcements dated 29 August 2025, 26 November 2025, 5 December 2025, 23 January 2026 and 26 January 2026, as well as the circular to shareholders of the Company dated 23 January 2026 in relation to the Proposed Listing of SHH. Unless otherwise stated, the terms used herein shall have the same meaning as defined in the said announcements.

On behalf of the Board, Maybank Investment Bank Berhad and AmInvestment Bank Berhad wish to announce that Bursa Securities had, vide its letter dated 30 January 2026, resolved to approve the following:

(i)     admission of SHH to the Official List and the listing and quotation of the entire issued share capital of 11,500,165,558 SHH Shares under the “Health Care” sector of the Main  Market of Bursa Securities; and

(ii)    listing and quotation of such number of new SHH Shares, representing up to 5% of the total number of issued ordinary shares of SHH, to be issued pursuant to the exercise of options under the Proposed ESOS.

SHH and the Joint Principal Advisers are required to comply with, among others, the following:

(i)      make the relevant announcements pursuant to Paragraphs 8.1 and 8.2 of Practice Note 21 of the Main Market Listing Requirements of Bursa Securities (“Listing Requirements”);

(ii)     make an immediate announcement upon the closing date of the offer that the IPO of SHH is subject to stabilising action;

(iii)    on the first day of listing, to furnish Bursa Securities with a copy of a schedule of distribution showing compliance with the public share spread requirements based on the entire issued share capital of SHH;

(iv)    furnish to Bursa Securities a confirmation on the full compliance of the Proposed ESOS pursuant to Paragraph 6.43(1) of the Listing Requirements together with the disclosure on the effective date of implementation; and

(v)     furnish to Bursa Securities with a summary of the total number of SHH Shares listed on a quarterly basis pursuant to the Proposed ESOS as at the end of each quarter together with a detailed computation of listing fees payable.

SHH is required to ensure full compliance of all the requirements as provided under the Listing Requirements at all times.

This Announcement is dated 30 January 2026.

This material does not constitute an offer for sale of the securities of SHH in the United States of America (“United States” or “U.S.”). The securities may not be offered, sold or delivered in the United States absent registration or an exemption from the registration requirements under the U.S. Securities Act of 1933, as amended. SHH does not intend to register any portion of the offering in the United States or to conduct a public offering of its securities in the United States.